Novel CS1 CAR-T Cells and Bispecific CS1-BCMA CAR-T Cells Effectively Target Multiple Myeloma

被引：14

作者：

Golubovskaya, Vita ^{[1
]}

Zhou, Hua ^{[1
]}

Li, Feng ^{[1
,2
]}

Berahovich, Robert ^{[1
]}

Sun, Jinying ^{[1
]}

Valentine, Michael ^{[1
]}

Xu, Shirley ^{[1
]}

Harto, Hizkia ^{[1
]}

Sienkiewicz, John ^{[1
]}

Huang, Yanwei ^{[1
]}

Wu, Lijun ^{[1
,3
]}

机构：

[1] Promab Biotechnol, 2600 Hilltop Dr, Richmond, CA 94806 USA

[2] Hunan Univ Arts & Sci, Biol & Environm Sci Coll, Changde 415000, Peoples R China

[3] Forevertek Biotechnol, Janshan Rd, Changsha 410205, Peoples R China

来源：

BIOMEDICINES | 2021年 / 9卷 / 10期

关键词：

chimeric antigen receptor; CAR-T cells; CS1; BCMA; immunotherapy; cell therapy; tumor antigen; multiple myeloma; MATURATION ANTIGEN; RECEPTOR; THERAPY; CANCER; IMMUNOTHERAPY; SYSTEM; APRIL; BAFF; TACI; BCMA;

D O I：

10.3390/biomedicines9101422

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Multiple myeloma (MM) is a hematological cancer caused by abnormal proliferation of plasma cells in the bone marrow, and novel types of treatment are needed for this deadly disease. In this study, we aimed to develop novel CS1 CAR-T cells and bispecific CS1-BCMA CAR-T cells to specifically target multiple myeloma. We generated a new CS1 (CD319, SLAM-7) antibody, clone (7A8D5), which specifically recognized the CS1 antigen, and we applied it for the generation of CS1-CAR. CS1-CAR-T cells caused specific killing of CHO-CS1 target cells with secretion of IFN-gamma and targeted multiple myeloma cells. In addition, bispecific CS1-BCMA-41BB-CD3 CAR-T cells effectively killed CHO-CS1 and CHO-BCMA target cells, killed CS1/BCMA-positive multiple myeloma cells, and secreted IFN-gamma. Moreover, CS1-CAR-T cells and bispecific CS1-BCMA CAR-T cells effectively blocked MM1S multiple myeloma tumor growth in vivo. These data for the first time demonstrate that novel CS1 and bispecific CS1-BCMA-CAR-T cells are effective in targeting MM cells and provide a basis for future clinical trials.

引用

页数：11

共 50 条

[31] γ-SECRETASE INHIBITORS IMPROVE MULTIPLE MYELOMA BCMA CAR-T THERAPY
不详
CANCER DISCOVERY, 2019, 9 (11) : 1483 - 1483
[32] Developing a Novel Anti-Bcma CAR-T for Relapsed or Refractory Multiple Myeloma
Yao, Xin
Zhu, Shigui
Huang, Jiaqi
Qu, Xiaoyan
Zhu, Judy
Wei, Yutian
Lan, Liping
Lv, Xiaoteng
Wu, Junfeng
Wang, Rirfei
Yang, Dingzhu
Zheng, Chengxiao
Zhao, DiJun
Fan, Lei
Huang, Fei
Lu, Hua
Zhang, Chaocan
Chen, Cheng
Li, Yanfeng
Ren, Jiaqiang
Zhang, Li
Humphries, Michael
Li, Jianyong
Yao, Yihong
BLOOD, 2019, 134
[33] Antibody-drug conjugates, bispecific antibodies and CAR-T cells therapy in multiple myeloma
Tacchetti, Paola
Talarico, Marco
Barbato, Simona
Pantani, Lucia
Mancuso, Katia
Rizzello, Ilaria
Zamagni, Elena
Cavo, Michele
EXPERT REVIEW OF ANTICANCER THERAPY, 2024, 24 (06) : 379 - 395
[34] Current status of bispecific antibodies and CAR-T therapies in multiple myeloma
Szlasa, Wojciech
Dybko, Jaroslaw
INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 134
[35] Timing and Nature of Infections in Multiple Myeloma Patients Treated with Anti-BCMA CAR-T Cells
Lancman, Guido
Shyu, Margaret
Metzger, Megan
Parsa, Kian
Cho, Hearn J.
Parekh, Samir
Richter, Joshua
Rodriguez, Cesar
Rossi, Adriana
Sanchez, Larysa
Thibaud, Santiago
Jagannath, Sundar
Chari, Ajai
Richard, Shambavi
BLOOD, 2022, 140 : 7198 - 7199
[36] Canadian-made single domain antibody (sdAb) BCMA CAR-T cells for multiple myeloma
Lindo, Lorenzo
Waller, Daniel
Wilkinson, Lauren
Selleri, Silvia
Arbabi-Ghahroudi, Mehdi
McComb, Scott
Bergsagel, Leif
Chesi, Marta
Hay, Kevin
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S48 - S49
[37] Clinical Outcomes of BCMA CAR-T Cells in a Multiple Myeloma Patient With Central Nervous System Invasion
Wang, Ting
He, Ting
Ma, Lie
Yang, Yazi
Feng, Ru
Ding, Yanping
Shan, Yueming
Bu, Bing
Qi, Feifei
Wu, Fei
Lu, Xin-an
Liu, Hui
FRONTIERS IN ONCOLOGY, 2022, 12
[38] The CAR-T cells are here
Croizier, Carolyne
Douge, Aurore
Bay, Jacques-Olivier
Lemal, Richard
BULLETIN DU CANCER, 2018, 105 (09) : 743 - 745
[39] Engineering CAR-T cells
Zhang, Cheng
Liu, Jun
Zhong, Jiang F.
Zhang, Xi
BIOMARKER RESEARCH, 2017, 5
[40] Activation-Inducible Bispecific BCMA-CD24 CAR-T Cells Precisely and Safely Control Multiple Myeloma Growth
Sun, Fumou
Dong, Jing
Hematti, Peiman
Janz, Siegfried
Dhakal, Binod
BLOOD, 2024, 144 : 4791 - 4792

← 1 2 3 4 5 →